U.S. FDA Approves Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels
The U.S. Food and Drug Administration (FDA) has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid (HA) gels, the first two products in Evolus, Inc.’s Evolysse collection. “This milestone represents an exciting new chapter in our long-term strategy to expand our portfolio and transition from a single-product company to a multi-product innovator, strengthening our leadership in performance […]